ACLU and PUBPAT Ask Supreme Court to Rule that Patents on Breast Cancer Genes Are Invalid

A federal district court previously invalidated all of the challenged BRCA patents. However, in August, a federal appeals court ruled for the second time that companies can obtain patents on the genes.

“In our view, the court of appeals did not fully consider or correctly apply the Supreme Court’s most recent and relevant patent law decisions," said Chris Hansen, staff attorney with the ACLU. “DNA occurs naturally in the human body and cannot be patented by a single company that can then use its patents to limit scientific research and the free exchange of ideas.”

Visit: http://www.aclu.org/womens-rights/aclu-and-pubpat-ask-supreme-court-rule-patents-breast-cancer-genes-are-invalid to read more!